Frontiers in Immunology (Mar 2022)

O-Linked β-N-Acetylglucosamine Modification: Linking Hypertension and the Immune System

  • Rinaldo Rodrigues dos Passos Junior,
  • Rinaldo Rodrigues dos Passos Junior,
  • Gisele Facholi Bomfim,
  • Fernanda R. Giachini,
  • Fernanda R. Giachini,
  • Rita C. Tostes,
  • Victor Vitorino Lima

DOI
https://doi.org/10.3389/fimmu.2022.852115
Journal volume & issue
Vol. 13

Abstract

Read online

The O-linked β-N-acetylglucosamine modification (O-GlcNAcylation) of proteins dynamically regulates protein function, localization, stability, and interactions. This post-translational modification is intimately linked to cardiovascular disease, including hypertension. An increasing number of studies suggest that components of innate and adaptive immunity, active players in the pathophysiology of hypertension, are targets for O-GlcNAcylation. In this review, we highlight the potential roles of O-GlcNAcylation in the immune system and discuss how those immune targets of O-GlcNAcylation may contribute to arterial hypertension.

Keywords